MedTrace Logo

Streptococcus Mutans Reduction Early Mother-infant Transmission

NCT04868513 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2021-05-03

No results posted yet for this study

Summary

Evidence exists on the vertical transmission of Streptococcus mutans from the mother to her children. This transmission can be prevented by maintaining maternal oral health during pregnancy.

Conditions

  • Pregnant Women

Interventions

DRUG

Pregnant women to whom applied silane fluoride

Pregnant women who received 0.1% silane fluoride applied as varnish in the teeth.

DRUG

Pregnant women to whom applied silane fluoride + 1% chlorhexidine

Pregnant women who received silane fluoride + 1% chlorhexidine applied as varnish in the teeth.

Sponsors & Collaborators

  • Biochemical and Microbiology Laboratory, Faculty of Dentistry, Autonomous University of San Luis Pot

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2017-10-31
Completion
2017-12-31
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04868513 on ClinicalTrials.gov